Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of Zhejiang University. Science. B ; (12): 42-52, 2020.
Article in English | WPRIM | ID: wpr-1010514

ABSTRACT

Osteoarthritis (OA) is a degenerative articular disorder manifested by cartilage destruction, subchondral sclerosis, osteophytes, and synovitis, resulting in chronic joint pain and physical disability in the elderly. The purpose of this study was to investigate mitochondrial DNA copy number (mtDNACN) and inflammatory cytokines in primary knee OA patients and healthy volunteers. A total of 204 knee OA patients and 169 age-matched healthy volunteers were recruited. Their relative blood leukocyte mtDNACN was assessed by quantitative real-time polymerase chain reaction (qRT-PCR), and ten inflammatory cytokines in their plasma were detected by multiplex immunoassay. Blood leukocyte mtDNACN in the OA group was significantly lower than that in the control group. Leukocyte mtDNACN in the control group was negatively correlated with their age (r=-0.380, P<0.0001), whereas mtDNACN in the OA group was positively correlated with their age (r=0.198, P<0.001). Plasma interleukin-4 (IL-4) and IL-6 were significantly higher in the knee OA group than in the control group. The plasma IL-6 level was positively correlated with blood leukocyte mtDNACN in the OA group (r=0.547, P=0.0014). IL-5 showed as a major factor (coefficient 0.69) in the second dimension of principle components analysis (PCA)-transformed data and was significantly higher in the OA group (P<0.001) as well as negatively correlated with mtDNACN (r=-0.577, P<0.001). These findings suggest that elevation of plasma IL-4 and IL-6 and a relative reduction in mtDNACN might be effective biomarkers for knee OA. IL-5 is a plausible factor responsible for decreasing blood leukocyte mtDNACN in knee OA patients.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Age Factors , Cytokines/blood , DNA, Mitochondrial/blood , Gene Dosage , Leukocytes/metabolism , Osteoarthritis, Knee/metabolism , Principal Component Analysis
2.
Clinics in Orthopedic Surgery ; : 358-360, 2014.
Article in English | WPRIM | ID: wpr-106807

ABSTRACT

Zoledronic acid has been used for prevention of osteolytic and osteoblastic bone metastasis. This case report illustrates an undesirable consequence from prolonged usage of zoledronic acid in bone metastasis prevention. Periprosthetic acetabular fracture in a patient treated with zoledronic acid for 7 years was reported. The clinical presentation, radiographic and pathological results were described. This is a rare complication after total hip arthroplasty which should not be ignored especially in patients who received long term bisphosphonate.


Subject(s)
Aged , Female , Humans , Acetabulum/injuries , Arthroplasty, Replacement, Hip/adverse effects , Bone Density Conservation Agents/adverse effects , Bone Neoplasms/prevention & control , Bone Remodeling/drug effects , Breast Neoplasms/pathology , Diphosphonates/adverse effects , Fractures, Spontaneous/chemically induced , Hip Prosthesis , Imidazoles/adverse effects , Osteoarthritis, Hip/surgery , Periprosthetic Fractures/chemically induced , Prosthesis Failure , Reoperation
SELECTION OF CITATIONS
SEARCH DETAIL